Stueland Katherine, CEO of GeneDx Holdings Corp. ($WGS), sold shares on the open market 57 times over the last 365 days, totaling $20.3 million. Her most recent sale occurred on March 9, 2026. These sales rank 669th among 11,678 individual insiders, surpassing the average sale value of $8.6 million and average of 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 80000 | $0.00 | 138,447.0000 | 28,904,590 | 136.88% | 0.28% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 80000 | $0.00 | 160,000.0000 | 28,904,590 | 33.33% | 0.28% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 9883 | $65.21 | 91,514.0000 | 28,904,590 | 9.75% | 0.03% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 5292 | $64.60 | 101,397.0000 | 28,904,590 | 4.96% | 0.02% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 13412 | $63.28 | 106,689.0000 | 28,904,590 | 11.17% | 0.05% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 5117 | $62.33 | 120,101.0000 | 28,904,590 | 4.09% | 0.02% |
| March 26, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 13229 | $61.29 | 125,218.0000 | 28,904,590 | 9.56% | 0.05% |
| March 16, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 7178 | $76.35 | 68,448.0000 | 28,904,590 | 9.49% | 0.02% |
| March 16, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 18750 | $0.00 | 75,000.0000 | 28,904,590 | 20.00% | 0.06% |
| March 15, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 11921 | $0.00 | 35,763.0000 | 28,904,590 | 25.00% | 0.04% |
| March 16, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 772 | $77.94 | 58,447.0000 | 28,904,590 | 1.30% | 0.00% |
| March 15, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 11921 | $0.00 | 56,876.0000 | 28,904,590 | 26.52% | 0.04% |
| March 16, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 18750 | $0.00 | 75,626.0000 | 28,904,590 | 32.97% | 0.06% |
| March 16, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 9229 | $77.05 | 59,219.0000 | 28,904,590 | 13.48% | 0.03% |
| March 9, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 3678 | $86.75 | 44,955.0000 | 28,904,590 | 7.56% | 0.01% |
| March 9, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 6546 | $0.00 | 48,633.0000 | 28,904,590 | 15.55% | 0.02% |
| March 9, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6546 | $0.00 | 19,640.0000 | 28,904,590 | 25.00% | 0.02% |
| March 6, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | A | Class A Common Stock | 3404 | $88.11 | 42,087.0000 | 28,904,590 | 8.80% | 0.01% |
| March 4, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 9133 | $79.25 | 38,683.0000 | 28,904,590 | 19.10% | 0.03% |
| March 4, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 5861 | $77.63 | 58,281.0000 | 28,904,590 | 9.14% | 0.02% |
| March 3, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | A | Class A Common Stock | 47684 | $0.00 | 64,142.0000 | 28,904,590 | 289.73% | 0.16% |
| March 3, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Unit | 40418 | $0.00 | 40,418.0000 | 28,904,590 | 9999.99% | 0.14% |
| March 4, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 10465 | $78.61 | 47,816.0000 | 28,904,590 | 17.96% | 0.04% |
| Jan. 29, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 1653 | $94.00 | 16,458.0000 | 28,904,590 | 9.13% | 0.01% |
| Jan. 29, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 3874 | $0.00 | 3,874.0000 | 28,904,590 | 50.00% | 0.01% |
| Jan. 29, 2026 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 3874 | $0.00 | 18,111.0000 | 28,904,590 | 27.21% | 0.01% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 18750 | $0.00 | 93,750.0000 | 28,904,590 | 16.67% | 0.06% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 356 | $140.95 | 14,237.0000 | 28,904,590 | 2.44% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 74 | $150.75 | 14,593.0000 | 28,904,590 | 0.50% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 274 | $149.20 | 14,667.0000 | 28,904,590 | 1.83% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 932 | $148.55 | 14,941.0000 | 28,904,590 | 5.87% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 1970 | $146.93 | 15,873.0000 | 28,904,590 | 11.04% | 0.01% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 1628 | $145.36 | 17,843.0000 | 28,904,590 | 8.36% | 0.01% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 940 | $144.27 | 19,471.0000 | 28,904,590 | 4.61% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 604 | $142.12 | 20,411.0000 | 28,904,590 | 2.87% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 2679 | $141.20 | 21,015.0000 | 28,904,590 | 11.31% | 0.01% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 1031 | $140.08 | 23,694.0000 | 28,904,590 | 4.17% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 369 | $138.93 | 24,725.0000 | 28,904,590 | 1.47% | 0.00% |
| Dec. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 18750 | $0.00 | 25,094.0000 | 28,904,590 | 295.55% | 0.06% |
| Dec. 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 6547 | $0.00 | 9,983.0000 | 28,904,590 | 190.54% | 0.02% |
| Dec. 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6547 | $0.00 | 26,186.0000 | 28,904,590 | 20.00% | 0.02% |
| Dec. 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 3639 | $159.28 | 6,344.0000 | 28,904,590 | 36.45% | 0.01% |
| Oct. 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 4 | $136.75 | 3,436.0000 | 28,904,590 | 0.12% | 0.00% |
| Oct. 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 3874 | $0.00 | 5,594.0000 | 28,904,590 | 225.23% | 0.01% |
| Oct. 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 3874 | $0.00 | 7,748.0000 | 28,904,590 | 33.33% | 0.01% |
| Oct. 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 2154 | $136.54 | 3,440.0000 | 28,904,590 | 38.51% | 0.01% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 136 | $113.68 | 1,720.0000 | 28,068,274 | 7.33% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 606 | $105.10 | 13,972.0000 | 28,068,274 | 4.16% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 1092 | $106.69 | 12,880.0000 | 28,068,274 | 7.82% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 4462 | $107.61 | 8,418.0000 | 28,068,274 | 34.64% | 0.02% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 5163 | $108.55 | 3,255.0000 | 28,068,274 | 61.33% | 0.02% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 554 | $109.13 | 2,701.0000 | 28,068,274 | 17.02% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 200 | $110.23 | 2,501.0000 | 28,068,274 | 7.40% | 0.00% |
| Sept. 30, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 645 | $111.84 | 1,856.0000 | 28,068,274 | 25.79% | 0.00% |
| Sept. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 10501 | $121.47 | 14,578.0000 | 28,068,274 | 41.87% | 0.04% |
| Sept. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 18750 | $0.00 | 25,079.0000 | 28,068,274 | 296.26% | 0.07% |
| Sept. 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 18750 | $0.00 | 112,500.0000 | 28,068,274 | 14.29% | 0.07% |
| Sept. 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 18 | $129.08 | 6,329.0000 | 28,068,274 | 0.28% | 0.00% |
| Sept. 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 6546 | $0.00 | 9,986.0000 | 28,068,274 | 190.29% | 0.02% |
| Sept. 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3639 | $128.05 | 6,347.0000 | 28,068,274 | 36.44% | 0.01% |
| Sept. 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 6546 | $0.00 | 32,733.0000 | 28,068,274 | 16.67% | 0.02% |
| July 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 3874 | $0.00 | 11,622.0000 | 28,068,274 | 25.00% | 0.01% |
| July 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2154 | $105.31 | 3,440.0000 | 28,068,274 | 38.51% | 0.01% |
| July 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 3874 | $0.00 | 5,594.0000 | 28,068,274 | 225.23% | 0.01% |
| July 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3220 | $93.00 | 1,720.0000 | 28,068,274 | 65.18% | 0.01% |
| July 1, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2594 | $91.55 | 5,075.0000 | 28,068,274 | 33.82% | 0.01% |
| July 1, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 6928 | $90.68 | 7,669.0000 | 28,068,274 | 47.46% | 0.02% |
| July 1, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 135 | $92.46 | 4,940.0000 | 28,068,274 | 2.66% | 0.00% |
| June 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 10501 | $64.77 | 14,597.0000 | 28,068,274 | 41.84% | 0.04% |
| June 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 18750 | $0.00 | 131,250.0000 | 28,068,274 | 12.50% | 0.07% |
| June 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 18750 | $0.00 | 25,098.0000 | 28,068,274 | 295.37% | 0.07% |
| June 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 6547 | $0.00 | 9,987.0000 | 28,068,274 | 190.32% | 0.02% |
| June 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3639 | $72.55 | 6,348.0000 | 28,068,274 | 36.44% | 0.01% |
| June 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 6547 | $0.00 | 39,279.0000 | 28,068,274 | 14.29% | 0.02% |
| April 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2154 | $113.09 | 3,440.0000 | 28,068,274 | 38.51% | 0.01% |
| April 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 3874 | $0.00 | 15,496.0000 | 28,068,274 | 20.00% | 0.01% |
| April 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 3874 | $0.00 | 5,594.0000 | 28,068,274 | 225.23% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2024 | $81.16 | 46,290.0000 | 28,068,274 | 4.19% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3134 | $82.17 | 43,156.0000 | 28,068,274 | 6.77% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3297 | $83.25 | 39,859.0000 | 28,068,274 | 7.64% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2745 | $84.28 | 37,114.0000 | 28,068,274 | 6.89% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3175 | $85.44 | 33,939.0000 | 28,068,274 | 8.55% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 5855 | $86.34 | 28,084.0000 | 28,068,274 | 17.25% | 0.02% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 373 | $87.30 | 27,711.0000 | 28,068,274 | 1.33% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 300 | $88.70 | 27,411.0000 | 28,068,274 | 1.08% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 1600 | $90.13 | 25,811.0000 | 28,068,274 | 5.84% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 1900 | $91.27 | 23,911.0000 | 28,068,274 | 7.36% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 1000 | $92.28 | 22,911.0000 | 28,068,274 | 4.18% | 0.00% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 9628 | $93.33 | 13,283.0000 | 28,068,274 | 42.02% | 0.03% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 4511 | $94.55 | 8,772.0000 | 28,068,274 | 33.96% | 0.02% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3173 | $95.51 | 5,599.0000 | 28,068,274 | 36.17% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3174 | $96.29 | 2,425.0000 | 28,068,274 | 56.69% | 0.01% |
| April 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 705 | $97.24 | 1,720.0000 | 28,068,274 | 29.07% | 0.00% |
| March 26, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 44801 | $95.66 | 50,064.0000 | 28,068,274 | 47.23% | 0.16% |
| March 26, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 80000 | $0.00 | 240,000.0000 | 28,068,274 | 25.00% | 0.29% |
| March 26, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 1750 | $94.59 | 48,314.0000 | 28,068,274 | 3.50% | 0.01% |
| March 26, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 80000 | $0.00 | 94,865.0000 | 28,068,274 | 538.18% | 0.29% |
| March 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 18750 | $0.00 | 150,000.0000 | 28,068,274 | 11.11% | 0.07% |
| March 17, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 10559 | $96.71 | 14,865.0000 | 28,068,274 | 41.53% | 0.04% |
| March 26, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | A | Restricted Stock Unit | 320000 | $0.00 | 320,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | A | Restricted Stock Unit | 47684 | $0.00 | 47,684.0000 | 28,068,274 | 9999.99% | 0.17% |
| March 13, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 1078 | $89.44 | 6,674.0000 | 28,068,274 | 13.91% | 0.00% |
| March 16, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 18750 | $0.00 | 25,424.0000 | 28,068,274 | 280.94% | 0.07% |
| March 10, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2731 | $94.73 | 7,752.0000 | 28,068,274 | 26.05% | 0.01% |
| March 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 6546 | $0.00 | 45,826.0000 | 28,068,274 | 12.50% | 0.02% |
| March 9, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 6546 | $0.00 | 10,483.0000 | 28,068,274 | 166.27% | 0.02% |
| Jan. 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 3874 | $0.00 | 19,370.0000 | 0 | 16.67% | 0.00% |
| Jan. 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 3874 | $0.00 | 5,594.0000 | 0 | 225.23% | 0.00% |
| Jan. 29, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 1657 | $78.48 | 3,937.0000 | 0 | 29.62% | 0.00% |
| Jan. 7, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 8439 | $94.33 | 20,901.0000 | 0 | 28.76% | 0.00% |
| Jan. 7, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 23800 | $93.34 | 29,340.0000 | 0 | 44.79% | 0.00% |
| Jan. 7, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 9176 | $95.50 | 11,725.0000 | 0 | 43.90% | 0.00% |
| Jan. 7, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 10005 | $96.39 | 1,720.0000 | 0 | 85.33% | 0.00% |
| Jan. 2, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 1564 | $80.47 | 53,140.0000 | 0 | 2.86% | 0.00% |
| Jan. 2, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2654 | $75.47 | 68,492.0000 | 0 | 3.73% | 0.00% |
| Jan. 2, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2051 | $76.54 | 66,441.0000 | 0 | 2.99% | 0.00% |
| Jan. 2, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3417 | $77.88 | 63,024.0000 | 0 | 5.14% | 0.00% |
| Jan. 2, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 4078 | $78.58 | 58,946.0000 | 0 | 6.47% | 0.00% |
| Jan. 2, 2025 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 4242 | $79.68 | 54,704.0000 | 0 | 7.20% | 0.00% |
| Dec. 16, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 18750 | $0.00 | 81,647.0000 | 0 | 29.81% | 0.00% |
| Dec. 16, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 18750 | $0.00 | 168,750.0000 | 0 | 10.00% | 0.00% |
| Dec. 16, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 10501 | $76.75 | 71,146.0000 | 0 | 12.86% | 0.00% |
| Dec. 9, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3661 | $76.37 | 62,897.0000 | 0 | 5.50% | 0.00% |
| Dec. 9, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 6547 | $0.00 | 52,372.0000 | 0 | 11.11% | 0.00% |
| Dec. 9, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 6547 | $0.00 | 66,558.0000 | 0 | 10.91% | 0.00% |
| Nov. 18, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 800 | $66.60 | 81,518.0000 | 0 | 0.97% | 0.00% |
| Nov. 15, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 60 | $74.34 | 82,318.0000 | 0 | 0.07% | 0.00% |
| Nov. 15, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 1510 | $73.71 | 82,378.0000 | 0 | 1.80% | 0.00% |
| Nov. 15, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2043 | $72.95 | 83,888.0000 | 0 | 2.38% | 0.00% |
| Nov. 15, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 1958 | $71.49 | 85,931.0000 | 0 | 2.23% | 0.00% |
| Nov. 18, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 6186 | $70.15 | 71,722.0000 | 0 | 7.94% | 0.00% |
| Nov. 15, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 5497 | $68.65 | 99,929.0000 | 0 | 5.21% | 0.00% |
| Nov. 18, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3131 | $71.83 | 60,011.0000 | 0 | 4.96% | 0.00% |
| Nov. 15, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 7240 | $70.72 | 87,889.0000 | 0 | 7.61% | 0.00% |
| Nov. 15, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 4800 | $69.67 | 95,129.0000 | 0 | 4.80% | 0.00% |
| Nov. 18, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 8580 | $70.91 | 63,142.0000 | 0 | 11.96% | 0.00% |
| Nov. 18, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3151 | $68.98 | 77,908.0000 | 0 | 3.89% | 0.00% |
| Nov. 18, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 459 | $67.94 | 81,059.0000 | 0 | 0.56% | 0.00% |
| Oct. 29, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2154 | $66.60 | 105,426.0000 | 0 | 2.00% | 0.00% |
| Oct. 29, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 3874 | $0.00 | 23,244.0000 | 0 | 14.29% | 0.00% |
| Oct. 29, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 3874 | $0.00 | 107,580.0000 | 0 | 3.74% | 0.00% |
| Sept. 16, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 18750 | $0.00 | 187,500.0000 | 0 | 9.09% | 0.00% |
| Sept. 16, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 10501 | $37.59 | 103,706.0000 | 0 | 9.19% | 0.00% |
| Sept. 16, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 18750 | $0.00 | 114,207.0000 | 0 | 19.64% | 0.00% |
| Sept. 9, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 6546 | $0.00 | 99,096.0000 | 0 | 7.07% | 0.00% |
| Sept. 9, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 6546 | $0.00 | 58,919.0000 | 0 | 10.00% | 0.00% |
| Sept. 9, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3639 | $33.33 | 95,457.0000 | 0 | 3.67% | 0.00% |
| July 29, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 3874 | $0.00 | 94,704.0000 | 0 | 4.27% | 0.00% |
| July 29, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2154 | $33.54 | 92,550.0000 | 0 | 2.27% | 0.00% |
| July 29, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 3874 | $0.00 | 27,118.0000 | 0 | 12.50% | 0.00% |
| June 16, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 18750 | $0.00 | 98,513.0000 | 0 | 23.51% | 0.00% |
| June 17, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 7683 | $28.31 | 90,830.0000 | 0 | 7.80% | 0.00% |
| June 16, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 18750 | $0.00 | 206,250.0000 | 0 | 8.33% | 0.00% |
| June 9, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 6546 | $0.00 | 65,465.0000 | 0 | 9.09% | 0.00% |
| June 9, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 6546 | $0.00 | 82,415.0000 | 0 | 8.63% | 0.00% |
| June 10, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2652 | $24.92 | 79,763.0000 | 0 | 3.22% | 0.00% |
| April 29, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 6325 | $11.04 | 75,869.0000 | 0 | 7.70% | 0.00% |
| April 29, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 15496 | $0.00 | 82,194.0000 | 0 | 23.23% | 0.00% |
| April 29, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 15496 | $0.00 | 30,992.0000 | 0 | 33.33% | 0.00% |
| March 16, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 18750 | $0.00 | 225,000.0000 | 0 | 7.69% | 0.00% |
| March 16, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 18750 | $0.00 | 75,257.0000 | 0 | 33.18% | 0.00% |
| March 18, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 8559 | $10.59 | 66,698.0000 | 0 | 11.37% | 0.00% |
| March 12, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | S | Class A Common Stock | 2618 | $9.21 | 56,507.0000 | 0 | 4.43% | 0.00% |
| March 9, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Class A Common Stock | 6547 | $0.00 | 59,125.0000 | 0 | 12.45% | 0.00% |
| March 9, 2024 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | CHIEF EXECUTIVE OFFICER | M | Restricted Stock Unit | 6547 | $0.00 | 72,011.0000 | 0 | 8.33% | 0.00% |
| Dec. 18, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 11734 | $2.16 | 52,578.0000 | 0 | 18.25% | 0.00% |
| Dec. 16, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 18750 | $0.00 | 64,312.0000 | 0 | 41.15% | 0.00% |
| Dec. 16, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 18750 | $0.00 | 243,750.0000 | 0 | 7.14% | 0.00% |
| Dec. 9, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 6546 | $0.00 | 78,558.0000 | 0 | 7.69% | 0.00% |
| Dec. 11, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 3673 | $1.61 | 45,562.0000 | 0 | 7.46% | 0.00% |
| Dec. 9, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 6546 | $0.00 | 49,235.0000 | 0 | 15.33% | 0.00% |
| Sept. 16, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 18750 | $0.00 | 53,441.0000 | 0 | 54.05% | 0.00% |
| Sept. 18, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 10752 | $4.16 | 42,689.0000 | 0 | 20.12% | 0.00% |
| Sept. 16, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 18750 | $0.00 | 262,500.0000 | 0 | 6.67% | 0.00% |
| Sept. 9, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 6547 | $0.00 | 85,104.0000 | 0 | 7.14% | 0.00% |
| Sept. 9, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 6547 | $0.00 | 37,366.0000 | 0 | 21.24% | 0.00% |
| Sept. 11, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2675 | $4.62 | 34,691.0000 | 0 | 7.16% | 0.00% |
| June 20, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 311 | $6.33 | 30,819.0000 | 0 | 1.00% | 0.00% |
| June 16, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 18750 | $0.00 | 38,784.0000 | 0 | 93.59% | 0.00% |
| June 20, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 7654 | $6.37 | 31,130.0000 | 0 | 19.73% | 0.00% |
| June 16, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 18750 | $0.00 | 281,250.0000 | 0 | 6.25% | 0.00% |
| June 9, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 6546 | $0.00 | 91,651.0000 | 0 | 6.67% | 0.00% |
| June 9, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 6546 | $0.00 | 22,708.0000 | 0 | 40.50% | 0.00% |
| June 12, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 2674 | $6.49 | 20,034.0000 | 0 | 11.78% | 0.00% |
| May 16, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 8685 | $6.50 | 16,162.0000 | 0 | 34.95% | 0.00% |
| April 29, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 511364 | $0.00 | 819,938.0000 | 0 | 38.41% | 0.00% |
| April 29, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 511364 | $0.00 | 1,534,090.0000 | 0 | 25.00% | 0.00% |
| April 26, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | A | Restricted Stock Unit | 9900000 | $0.00 | 9,900,000.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | S | Class A Common Stock | 92644 | $0.36 | 308,574.0000 | 0 | 23.09% | 0.00% |
| March 9, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Class A Common Stock | 216033 | $0.00 | 401,218.0000 | 0 | 116.66% | 0.00% |
| March 9, 2023 | GeneDx Holdings Corp. | $WGS | Stueland Katherine | Chief Executive Officer | M | Restricted Stock Unit | 216033 | $0.00 | 3,240,503.0000 | 0 | 6.25% | 0.00% |